This document is designed to help you prepare an abstract that
meets the criteria for FIP congresses. It is intended to be read alongside the
call for abstracts, which specifies the congress topic areas, and applies to
abstracts for oral presentations and posters.
An abstract is a short statement that gives the reader a
comprehensive yet concise understanding of your work. Your work could be
research, such as a study or clinical trial, or a new or unique service, programme, theory or resource.
An abstract is an opportunity to make your work known, inform
practice and/or education, and to establish connections with others in your
field of interest. It should tell readers what you are going to present and
interest them in learning more about your work — they may decide to attend your
presentation, visit your poster or contact you based on it.
Your abstract will have difference audiences:
·
Congress delegates
(pharmacists,
pharmaceutical scientists, students, educators, policy-makers and researchers) use
abstracts to select which sessions to attend.
·
Reviewers
will assess the quality of your
abstract and recommend its acceptance (and whether the work should be presented
orally or as a poster) or rejection.
·
Journal editors
use abstracts to look for papers
to encourage for publication.
·
People who can’t attend
the congress access abstracts online.
Your
abstract should contain information under the following
subheadings
:
·
Title
·
Background information
(Why is your work important? Does it fill any gaps in
knowledge or research? What is the context?)
·
Purpose
(What are the objectives? You may include a short statement
of your hypothesis.)
·
Method
(Explain your methods, such as study design. What was done,
by whom, how and where? What measurements were taken and how were the data
managed?)
·
Results
(What did you find, discover or achieve? Not just in
subjective terms, but also in the form of data. How significant were your
findings?)
·
Conclusion
(What were your overall findings? What do they mean? How
could the methods be improved? Is this work part of a bigger piece of research
or strategy? What are the suggestions for future work?)
·
Topic area
(Refer to the areas listed in the call for abstracts and
select the most appropriate so that the congress organisers
can place your abstract in the appropriate session.)
·
By submitting
your work to Arab Pharmacists Union ( APU), you
consent to have authors’ names, affiliation and biographical material used in
connection with the publication of your work.
·
Author(s)
represent(s) and warrant(s) that he/she/they is/are the sole author(s) of the
work, that all authors have participated in and agree with the content and
conclusions of the work, and that the work is original and does not infringe
upon any copyright, proprietary, or personal right of any third party. The
submitter affirms that the work submitted is original, except for extracts from
copyrighted works fully authorised by the copyright
holders, and that all statements declared as facts are based on thorough
examination and investigation for accurateness.
·
Submitted
abstracts should not have been published in any other journals and/or online
publications nor presented at any previous international congress. However,
former presentation at national meetings does not disqualify.
·
Submitted
abstracts must report new information not previously published or presented at
an international scientific meeting prior to the Congress. Note that abstracts
previously presented at international meetings will not be accepted unless
there is a substantial update of data..
·
The content
belongs to the author(s). However, if the abstract is accepted the submitter agrees,
on behalf of all co-authors, to transfer and assign to the APU the rights to
edit, publish, reproduce, distribute copies and prepare derivative works such
as press releases. This includes use in indexes or search databases in print,
electronic, or other media.
·
Author(s)
retain(s) the right, after presentation at the Congress, to subsequently
include the work in articles, books, or derivative works that he/she authors or
edits, provided said use does not imply the endorsement of APU.
·
The submitter signs for all co-authors. He/she accepts
responsibility for the present rules for submission and presentation on behalf
of all co-authors.
Rules for content and structure
·
Abstracts must be in British English.
(If you are not a native English speaker, you are advised to have your writing
reviewed by a native English speaker before submission.)
·
Abstracts should preferably contain
previously unpublished results.
·
Abstracts must be no more than 1,700
characters (including spaces), excluding the title and excluding the name(s)
and institutes/companies of the authors and co-authors.
·
All co-authors must be listed.
·
All listed co-authors must have
reviewed the abstract and accepted responsibility for its contents.
·
Abstract titles should not include
phone numbers, email or website addresses.
·
No images, tables or graphs are
permitted in the abstract.
·
Non-proprietary (generic) drug names
must be used wherever possible.
·
Active promotion of commercial
entities, products or services is not permitted.